Hebrew Site 

11/06/2002- Pharmos Corporation Reports 2002 Third Quarter and Nine Month Results (PDF file) 11/04/2002- Pharmos CB2-selective Agonist Compounds Demonstrate Efficacy in a Series of Pain Models 10/24/2002- Pharmos Corporation Adopts Stockholder Rights Plan and By-Law Revisions 10/21/2002- Pharmos Files Investigational New Drug Application for a Phase III Study of Dexanabinol to Treat TBI 08/05/2002- Pharmos Corporation Reports 2002 Second Quarter and Six Month Results (PDF file) 07/25/2002- Pharmos to Start Clinical Trial of Dexanabinol in Heart Surgery Patients 06/07/2002- Pharmos Corporation to Present at the BIO 2002 International Convention & Exhibition 06/06/2002- Pharmos Receives Grant from Israeli Government Agency 06/03/2002- Dr. Lawrence F. Marshall Joins Board of Pharmos Corporation 05/02/2002- Pharmos Corporation Reports 2002 First Quarter Results (PDF file) 03/07/2002- Pharmos Corporation Reports 2001 Results 02/25/2002- Compounds From Pharmos’ New Cannabis-like Platform Technology Selectively Bind to CB2 Receptors 02/19/2002- Pharmos Corporation to Present at the BIO CEO & Investor Conference 01/04/2002- Pharmos Corporation to Present at JPMorgan H&Q 20th Annual Healthcare Conference 01/03/2002- Pharmos Corporation Extends Maturity of Convertible Debentures

More News:

<< Recent News >>         << 2003 News >>         << 2001 News >>